Expertise in
23
conditions

Dr. Bradford A. Perez

Radiation Oncology
9320 State Road 54, 
Trinity, FL 
Accepting New Patients
Offers Telehealth
Expertise in
23
conditions
9320 State Road 54, 
Trinity, FL 

Overview

Bradford Perez is a Radiation Oncologist practicing medicine in Trinity, Florida.

Dr. Perez is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

Dr. Perez is board certified in American Board Of Radiology and AB Radiology - Radiation Oncology. He is actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 9 clinical trials. Dr. Perez is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in FL

Board Certifications

American Board Of Radiology
AB Radiology - Radiation Oncology

Hospital Affiliations

Morton Plant North Bay
Hca Florida Trinity Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Florida Cancer Specialist Pl
9320 State Road 54, Trinity, FL 34655

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Phase II Toxicity Study of Pleurectomy/Decortication, (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
Phase II Toxicity Study of Pleurectomy/Decortication, (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Procedure, Radiation, Drug
Study Drug: Pemetrexed+Cisplatin or carboplatin
Study Phase: Phase 2
Phase III Randomized Trial of Pleurectomy/Decortication Plus Systemic Therapy With or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma (MPM)
Phase III Randomized Trial of Pleurectomy/Decortication Plus Systemic Therapy With or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma (MPM)
Enrollment Status: Terminated
Publish Date: July 13, 2026
Intervention Type: Procedure, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Pemetrexed, Pemetrexed Disodium
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Enrollment Status: Active_not_recruiting
Publish Date: June 11, 2026
Intervention Type: Procedure, Radiation
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2026
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Sequential Maintenance With Thoracic Radiotherapy and Durvalumab (MEDI4736) Monotherapy or Durvalumab (MEDI 4736) Combinations (Tremelimumab or Olaparib) in Patients With Extensive Stage-Small Cell Lung Cancer After First Line Platinum Based Chemotherapy
Sequential Maintenance With Thoracic Radiotherapy and Durvalumab (MEDI4736) Monotherapy or Durvalumab (MEDI 4736) Combinations (Tremelimumab or Olaparib) in Patients With Extensive Stage-Small Cell Lung Cancer After First Line Platinum Based Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: April 01, 2026
Intervention Type: Drug, Radiation
Study Drugs: Durvalumab, Tremelimumab, Olaparib
Study Phase: Phase 1
Consolidative Ipilimumab and Nivolumab With Thoracic Radiotherapy After Platinum Based Chemotherapy for Patients With Extensive-Stage Small Cell Lung Cancer
Consolidative Ipilimumab and Nivolumab With Thoracic Radiotherapy After Platinum Based Chemotherapy for Patients With Extensive-Stage Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: December 20, 2024
Intervention Type: Radiation, Drug
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 1/Phase 2
Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable NSCLC
Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable NSCLC
Enrollment Status: Terminated
Publish Date: February 15, 2023
Intervention Type: Drug, Radiation
Study Drugs: Platinum Based Chemotherapy, Ipilimumab, Nivolumab
Study Phase: Phase 1/Phase 2
View 8 Less Clinical Trials

52 Total Publications

CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion.
CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion.
Journal: Journal for immunotherapy of cancer
Published: March 24, 2025
Similar Doctors
Expertise in
22
conditions
Dr. Sarah E. Hoffe
Radiation Oncology
Expertise in
22
conditions
Dr. Sarah E. Hoffe
Radiation Oncology
Referral may be required

Moffitt Cancer Center, Magnolia Campus

12902 Usf Magnolia Dr, 
Tampa, FL 
 (17.7 miles away)
813-692-4124
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sarah Hoffe is a Radiation Oncologist practicing medicine in Tampa, Florida. Dr. Hoffe is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Anal Cancer, Esophageal Cancer, Lymphadenectomy, and Pancreaticoduodenectomy. Dr. Hoffe is currently accepting new patients.

Expertise in
34
conditions
Dr. Peter A. Johnstone
Radiation Oncology
Expertise in
34
conditions
Dr. Peter A. Johnstone
Radiation Oncology
Referral may be required

Moffitt Cancer Center

12902 Usf Magnolia Dr, 
Tampa, FL 
 (17.7 miles away)
813-745-6161
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Johnstone is a Radiation Oncologist practicing medicine in Tampa, Florida. Dr. Johnstone is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Penile Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, Penectomy, and Orchiectomy. Dr. Johnstone is board certified in AB Radiology - Radiation Oncology. Dr. Johnstone is currently accepting new patients.

Expertise in
24
conditions
Dr. Kamran A. Ahmed
Radiation Oncology
Expertise in
24
conditions
Dr. Kamran A. Ahmed
Radiation Oncology
Referral may be required

Moffitt Cancer Center, Richard M. Schulze Family Foundation Outpatient Center At McKinley Campus

10920 McKinley Dr, 
Tampa, FL 
 (18.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kamran Ahmed is a Radiation Oncologist practicing medicine in Tampa, Florida. Dr. Ahmed is highly rated in 24 conditions, according to our data. His clinical expertise encompasses HER-2 Positive Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, HER2 Negative Breast Cancer, and Tissue Biopsy. Dr. Ahmed is currently accepting new patients.

Frequently Asked Questions about Dr. Bradford A. Perez

How do I make an appointment with Dr. Bradford A. Perez?

You can book an appointment with Dr. Bradford A. Perez by calling their office at 727-842-8411. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bradford A. Perez a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bradford A. Perez is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bradford A. Perez specialize in?

While Dr. Bradford A. Perez is a Radiation Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Posterior Fossa Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Bradford A. Perez participate in research or clinical trials?

Yes. Dr. Bradford A. Perez has published 52 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Bradford A. Perez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Bradford A. Perez accept my insurance?

Dr. Bradford A. Perez accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 727-842-8411 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Perez's expertise for a condition
ConditionClose
    View All 19 Advanced Conditions
    View All 54 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile